Delivery Order SPE2DE24DA010-SPE2D626F69N6
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $34,732.80 fixed-price delivery order (Contract No. 4570178737, "GALLANT") from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with completion scheduled for December 4, 2025. The award, issued through full and open competition with no set-aside designation, supports the agency's medical supply procurement operations at Abbott's Santa Clara, California facility. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F69N6Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a $34,732.80 fixed-price delivery order (Contract 4570380875, GALLANT) from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion targeted for January 6, 2026. The delivery order, issued without set-aside designation, will be performed in Santa Clara, California, and represents a task order execution under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages. This award aligns with Abbott Vascular's established role as a critical federal supplier of advanced cardiovascular medical technologies, including stents, pacemakers, heart valves, and other implantable cardiac devices that support military and veteran healthcare delivery. This contract award reflects Abbott Laboratories' dominant market position in federal cardiovascular device procurement, supported by its demonstrated competitive success through full and open competition mechanisms across multiple federal healthcare agencies. The award is structured with fixed-price pricing incorporating economic price adjustment provisions, consistent with the company's standard federal contracting approach. Abbott's extensive portfolio of Indefinite Delivery Contracts—including the $117.1 million Defense Logistics Agency cardiovascular device vehicle and multiple Veterans Integrated Service Network single-award contracts valued up to $1.13 million—positions the company to fulfill specialized medical device requirements across federal healthcare systems efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 12/10/25 |